Bausch Health Cos Long Term Debt 2006-2021 | BHC

Bausch Health Cos long term debt from 2006 to 2021. Long term debt can be defined as the sum of all long term debt fields.
  • Bausch Health Cos long term debt for the quarter ending June 30, 2021 was $23.439B, a 3.77% decline year-over-year.
  • Bausch Health Cos long term debt for 2020 was $23.925B, a 2.98% decline from 2019.
  • Bausch Health Cos long term debt for 2019 was $24.661B, a 2.43% increase from 2018.
  • Bausch Health Cos long term debt for 2018 was $24.077B, a 4.59% decline from 2017.
Bausch Health Cos Annual Long Term Debt
(Millions of US $)
2020 $23,925
2019 $24,661
2018 $24,077
2017 $25,235
2016 $29,845
2015 $30,265
2014 $15,228
2013 $17,163
2012 $10,535
2011 $6,540
2010 $3,478
2009 $314
2008 $
2007 $
2006 $401
2005 $413
Bausch Health Cos Quarterly Long Term Debt
(Millions of US $)
2021-06-30 $23,439
2021-03-31 $23,738
2020-12-31 $23,925
2020-09-30 $24,343
2020-06-30 $24,357
2020-03-31
2019-12-31 $24,661
2019-09-30 $23,466
2019-06-30 $24,023
2019-03-31 $23,924
2018-12-31 $24,077
2018-09-30 $24,433
2018-06-30 $24,858
2018-03-31 $25,266
2017-12-31 $25,235
2017-09-30 $26,216
2017-06-30 $27,648
2017-03-31 $28,198
2016-12-31 $29,845
2016-09-30 $30,386
2016-06-30 $30,773
2016-03-31 $31,303
2015-12-31 $30,265
2015-09-30 $30,176
2015-06-30 $30,290
2015-03-31 $25,898
2014-12-31 $15,228
2014-09-30 $15,584
2014-06-30 $17,059
2014-03-31 $17,148
2013-12-31 $17,163
2013-09-30 $17,044
2013-06-30 $10,447
2013-03-31 $10,327
2012-12-31 $10,535
2012-09-30 $7,423
2012-06-30 $7,356
2012-03-31 $6,851
2011-12-31 $6,540
2011-09-30 $5,188
2011-06-30 $4,529
2011-03-31 $4,699
2010-12-31 $3,478
2010-09-30 $3,114
2010-06-30 $303
2010-03-31 $317
2009-12-31 $314
2009-09-30
2009-06-30
2009-03-31
2008-12-31
2008-09-30
2008-06-30
2008-03-31
2007-12-31
2007-09-30
2007-06-30
2007-03-31 $1
2006-12-31 $401
2006-09-30 $401
2006-06-30 $401
2006-03-31 $401
2005-12-31 $413
2005-09-30 $423
2005-06-30 $424
2005-03-31 $431
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $10.293B $8.027B
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $11.172B 4.27
Dr Reddy's Laboratories (RDY) India $10.201B 31.45